hydralazine has been researched along with Idiopathic Parkinson Disease in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehrabani, M | 1 |
| Nematollahi, MH | 1 |
| Tarzi, ME | 1 |
| Juybari, KB | 1 |
| Abolhassani, M | 1 |
| Sharifi, AM | 1 |
| Paseban, H | 1 |
| Saravani, M | 1 |
| Mirzamohammadi, S | 1 |
1 other study available for hydralazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Protective effect of hydralazine on a cellular model of Parkinson's disease: a possible role of hypoxia-inducible factor (HIF)-1α.
Topics: Antioxidants; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Dopamine; Humans; Hydralazin | 2020 |